Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 1026 - 1049 of 1049 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Hydralazine	Approved	REN	5972	increased	Hydralazine results in increased expression of REN protein	1q32.1	A27110 A26516
Furosemide	Approved Vet Approved	REN	5972	increased	Furosemide results in increased expression of REN protein	1q32.1	A26462 A26463
Furosemide	Approved Vet Approved	REN	5972	increased	Furosemide results in increased expression of REN protein	1q32.1	A26462 A26463
Ritodrine	Approved Investigational	INS	3630	increased	Ritodrine results in increased expression of INS protein	11p15.5	A27111 A27112 A26485
Ritodrine	Approved Investigational	INS	3630	increased	Ritodrine results in increased expression of INS protein	11p15.5	A27111 A27112 A26485
Epinephrine	Approved Vet Approved	INS	3630	decreased	Epinephrine results in decreased expression of INS protein	11p15.5	A27113 A27114
Epinephrine	Approved Vet Approved	INS	3630	decreased	Epinephrine results in decreased expression of INS protein	11p15.5	A27113 A27114
Chlorpromazine	Approved Investigational Vet Approved	PRL	5617	increased	Chlorpromazine results in increased expression of PRL protein	6p22.3	A27115 A27116
Chlorpromazine	Approved Investigational Vet Approved	PRL	5617	increased	Chlorpromazine results in increased expression of PRL protein	6p22.3	A27115 A27116
Spironolactone	Approved	AGT	183	increased	Spironolactone results in increased expression of AGT protein modified form	1q42.2	A26031 A26592
Spironolactone	Approved	AGT	183	increased	Spironolactone results in increased expression of AGT protein modified form	1q42.2	A26031 A26592
Heparin	Approved Investigational	SERPINC1	462	decreased	Heparin results in decreased expression of SERPINC1 protein	1q25.1	A27117 A27118
Hydrocortisone	Approved Vet Approved	INS	3630	increased	Hydrocortisone results in increased expression of INS protein	11p15.5	A26568 A27119 A27120
Hydrocortisone	Approved Vet Approved	INS	3630	increased	Hydrocortisone results in increased expression of INS protein	11p15.5	A26568 A27119 A27120
Octreotide	Approved Investigational	INS	3630	decreased	Octreotide results in decreased expression of INS protein	11p15.5	A27121 A27120
Methotrexate	Approved	COL3A1	1281	increased	Methotrexate results in increased expression of COL3A1 protein	2q32.2	A27122 A27123
Beclomethasone dipropionate	Approved Investigational	BGLAP	632	decreased	Beclomethasone results in decreased expression of BGLAP protein	1q22	A27124 A26588 A27125
Beclomethasone dipropionate	Approved Investigational	BGLAP	632	decreased	Beclomethasone results in decreased expression of BGLAP protein	1q22	A27124 A26588 A27125
Lansoprazole	Approved Investigational	GAST	2520	increased	Lansoprazole results in increased expression of GAST protein	17q21.2	A27126 A27127
Lansoprazole	Approved Investigational	GAST	2520	increased	Lansoprazole results in increased expression of GAST protein	17q21.2	A27126 A27127
Bezafibrate	Approved Investigational	APOA2	336	increased	Bezafibrate results in increased expression of APOA2 protein	1q23.3	A26488 A26489
Ifosfamide	Approved	B2M	567	increased	Ifosfamide results in increased expression of B2M protein	15q21.1	A27128 A27129
Ifosfamide	Approved	B2M	567	increased	Ifosfamide results in increased expression of B2M protein	15q21.1	A27128 A27129
Verapamil	Approved	PRL	5617	increased	Verapamil results in increased expression of PRL protein	6p22.3	A27130 A27131

Displaying entries 1026 - 1049 of 1049 in total

Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability